All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Insight into the pathogenesis of interstitial lung diseases and near-to-native lung fibrosis models

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F25%3A00083334" target="_blank" >RIV/65269705:_____/25:00083334 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/25:00143748 RIV/00159816:_____/25:00082352

  • Result on the web

    <a href="https://link.springer.com/article/10.1186/s40001-025-03504-4" target="_blank" >https://link.springer.com/article/10.1186/s40001-025-03504-4</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s40001-025-03504-4" target="_blank" >10.1186/s40001-025-03504-4</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Insight into the pathogenesis of interstitial lung diseases and near-to-native lung fibrosis models

  • Original language description

    Interstitial lung diseases (ILDs) is a large and heterogeneous group of disorders with a variable degree of lung inflammation and lung fibrosis. In some ILDs, we can observe a progressive-fibrosing phenotype-PF-ILD (e.g., idiopathic pulmonary fibrosis, fibrotic phenotype of hypersensitivity pneumonitis, familial lung fibrosis, etc.). Lung fibrosis is characterized by overgrowth, stiffening, and scarring of tissues due to excess deposition of extracellular matrix. In some patients suffering from PF-ILD, progression and fatal outcomes occur despite treatment. Therefore, there is a great need for the development of lung fibrosis models that will help to understand and recapitulate the etiopathogenesis of the disease and may thus serve as tools for unraveling its underlying profibrotic mechanisms and potential therapeutic targets. In this review, we summarize ILD etiopathogenesis, current and novel therapeutic options, and discuss in vivo, ex vivo, and in vitro near-to-native lung fibrosis models, which help to elucidate specific processes within ILD pathophysiology.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30100 - Basic medicine

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    European Journal of Medical Research

  • ISSN

    0949-2321

  • e-ISSN

    2047-783X

  • Volume of the periodical

    30

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    21

  • Pages from-to

    1232

  • UT code for WoS article

    001637734100003

  • EID of the result in the Scopus database